Fundz

Imugene Appoints Dr John Byon as Senior Vice President of Clinical Development

PRIVATESep 01, 2023

Position

Senior Vice President of Clinical Development

Company

Imugene

John Byon
jbyon@imugene.com
SydneyBiotechnologyHealth CareMedicalTherapeutics

Description

Dr John Byon has been named as senior vice president of clinical development, bringing a wealth of experience and expertise to that role. Dr Byon’s appointment comes just weeks after Imugene named Dr Bradley Glover as the company’s new chief operating officer.

Quick answer

Imugene Appoints Dr John Byon as Senior Vice President of Clinical Development (September 1, 2023). Imugene is based in Sydney, New South Wales, Australia.

Who is the new Senior Vice President of Clinical Development at Imugene?
Imugene named John Byon Senior Vice President of Clinical Development, announced September 1, 2023.
What did Imugene announce on September 1, 2023?
Dr John Byon has been named as senior vice president of clinical development, bringing a wealth of experience and expertise to that role. Dr Byon’s appointment comes just weeks after Imugene named Dr Bradley Glover as the company’s new chief operating officer.
What does Imugene do?
Imugene is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. onCARlytics (CF33-CD19) is a novel...
Where is Imugene based?
Imugene is based in Sydney, New South Wales, Australia.
Which similar companies made leadership changes around the same time?
Hansa Biopharma (September 1, 2023), Adverum Biotechnologies (August 21, 2023), 4D Molecular Therapeutics (September 12, 2023) and Arcutis (August 18, 2023) also announced leadership changes within 45 days of Imugene.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Imugene, and when

A new leader at Imugene brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Imugene raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Imugene, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Imugene. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Imugene

Location

Sydney, New South Wales, Australia

About

Imugene is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. onCARlytics (CF33-CD19) is a novel and effective combination immunotherapy utilising the CF33 oncolytic virus to deliver and present CD19 antigen on the surface of cancer cells promoting CD19 CAR T cell anti-tumour responses against solid tumours.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Imugene changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

John
Likely contact at this company
••••••••@••••••••

See John's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Imugene's next move

Learn about Strategic plan

Imugene changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.